Prospects for antibacterial therapy of prolonged and recurrent rhinogenous sinusitis, and sinusitis with comorbidities

Abstract

The problem of acute sinusitis (AS) continues to be relevant in today's healthcare, what is explained by several reasons. First of all, it is not only that the incidence of AS did not decrease over the past years; moreover, it demonstrates sustainable growth both in Russia and wordlwide. For example, 16% of the US adult population present with sinusitis every year. [1] In Russia, 10 million people suffer from AS every year, although the figure can be low since only severe manifestations of the disease are recorded. [2] According to the latest statistics from the Department of Health of Moscow, the prevalence of sinusitis is 1420 cases per 100 thousand adults. [3]

Keywords

• риногенный синусит
• антибактериальная терапия
• цефалоспорины
• спектрацеф
• rhinogenous sinusitis
• antibiotic therapy
• cephalosporins
• spectracef